BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3140592)

  • 1. Dihydroergocristine in stopping lactation: double-blind study vs bromocriptine.
    de Aloysio D; Pamparana F; Zanotti A; Fabiani AG; Bottiglioni F
    Gynecol Endocrinol; 1988 Mar; 2(1):67-71. PubMed ID: 3140592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of breast pain and milk secretion with bromocriptine after second-trimester abortion.
    Nyboe Andersen A; Damm P; Tabor A; Pedersen IM; Harring M
    Acta Obstet Gynecol Scand; 1990; 69(3):235-8. PubMed ID: 2220345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of puerperal lactation: evaluation of bromocriptine and placebo.
    Bhardwaj N
    Aust N Z J Obstet Gynaecol; 1979 Aug; 19(3):154-7. PubMed ID: 391210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cabergoline versus bromocriptine in suppression of lactation after cesarean delivery.
    Giorda G; de Vincentiis S; Motta T; Casazza S; Fadin M; D'Alberton A
    Gynecol Obstet Invest; 1991; 31(2):93-6. PubMed ID: 2037265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of lactation by a long-acting bromocriptine.
    Peters F; Del Pozo E; Conti A; Breckwoldt M
    Obstet Gynecol; 1986 Jan; 67(1):82-5. PubMed ID: 3940343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lactation suppression with bromocriptine.
    Hutchison P; Sill H
    N Z Med J; 1981 Oct; 94(694):309-10. PubMed ID: 7033847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single dose cabergoline versus bromocriptine in inhibition of puerperal lactation: randomised, double blind, multicentre study. European Multicentre Study Group for Cabergoline in Lactation Inhibition.
    BMJ; 1991 Jun; 302(6789):1367-71. PubMed ID: 1676318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of puerperal lactation: A comparative study of bromocriptine and pyridoxine.
    Boes EG
    S Afr Med J; 1980 May; 57(22):900-3. PubMed ID: 6996132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulpiride isomers and milk secretion in puerperium.
    Polatti F
    Clin Exp Obstet Gynecol; 1982; 9(3):144-7. PubMed ID: 6762263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of puerperal lactation by means of a single injection of bromocriptine retard.
    Valsamis J; Chavez H; Westelinck K; Haemers M; Francis G; L'Hermite M
    Eur J Obstet Gynecol Reprod Biol; 1987 May; 25(1):43-51. PubMed ID: 3595974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of puerperal lactation. A double blind study of bromocriptine and placebo.
    Dewhurst CJ; Harrison RF; Biswas S
    Acta Obstet Gynecol Scand; 1977; 56(4):327-31. PubMed ID: 341635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metergoline versus bromocriptine in the prevention of puerperal lactation. A double-blind clinical trial.
    Scapin F; Buonaccorsi S; Tronconi G; Pellicciotta G; Pontiroli AE
    Eur J Clin Pharmacol; 1982; 22(2):181-3. PubMed ID: 7047172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lactation-inhibiting and prolactin-lowering effect of lisuride and bromocriptine: a comparative study.
    Van Dam LJ; Rolland R
    Eur J Obstet Gynecol Reprod Biol; 1981 Nov; 12(5):323-30. PubMed ID: 7333409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of several sexual steroids, 2-bromo-ergokryptin and lisurid-hydrogenmaleate an the postpartum concentration of serum prolactin and lactation (author's transl)].
    Schmidt-Gollwitzer M; Hardt W; Schmidt-Gollwitzer K; Michel E; Nevinny-Stickel J
    Geburtshilfe Frauenheilkd; 1977 Jun; 37(6):500-8. PubMed ID: 328335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of bromocriptine versus breast binders as inhibitors of postpartum lactation.
    Shapiro AG; Thomas L
    South Med J; 1984 Jun; 77(6):719-21. PubMed ID: 6729548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cabergoline. A review of its pharmacological properties and therapeutic potential in the treatment of hyperprolactinaemia and inhibition of lactation.
    Rains CP; Bryson HM; Fitton A
    Drugs; 1995 Feb; 49(2):255-79. PubMed ID: 7729332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bromocriptine compared to long-acting estrogens in lactation prevention: clinical efficacy, prolactin secretion and coagulation parameters.
    Leleux D; Merveille JJ; Capel P; Picard C; L'Hermite M
    Eur J Obstet Gynecol Reprod Biol; 1981 Oct; 12(4):235-42. PubMed ID: 7197648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bromocriptine mesylate for prevention of postpartum lactation.
    Duchesne C; Leke R
    Obstet Gynecol; 1981 Apr; 57(4):464-7. PubMed ID: 7243095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of puerperal lactation with 2-mercaptopropionyl-glycine.
    Akrivis C; Vezyraki P; Kiortsis DN; Fotopoulos A; Evangelou A
    Eur J Clin Pharmacol; 2000 Dec; 56(9-10):621-3. PubMed ID: 11214766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of lactation by cyclofenil and bromocriptine.
    Thorbert G; Akerlund M
    Br J Obstet Gynaecol; 1983 Aug; 90(8):739-42. PubMed ID: 6411113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.